Antimicrobial activity of untenospongin b, a metabolite from the marine sponge hippospongia communis collected from the atlantic coast of Morocco

Marine Drugs

Volumn 2, Issue 3, 2004, Pages 147-153

  Rifai, Saida ^a   Fassouane, Aziz ^a   Kijjoa, Anake ^b   Van Soest, Rob ^c  

^a FACULTÉ DES SCIENCES   (Morocco)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

( ) untenospongin B; Antimicrobial activity; Hippospongia communis; Porifera

Indexed keywords

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOROCCO; NONHUMAN; SEASHORE; SPONGE (PORIFERA);

EID: 27644594723     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md203147     Document Type: Article

References (13)

1. Dannaoui, E.; Lortholary, O.; Dromer, F. Technique des associations d’antifongiques in vitro et in vivo chez l’animal. J. Mycol. Med. 2003, 13, 73-85.
2. Thiebaut, A. Empirical treatment by antifungal drugs in febrile neutropenia. J. Mycol. Med. 2002, 12, 115-119.
3. Lorthoraly, O.; Denning, W. D.; Dupont, B. Endemic mycoses: a treatment update. J. Antimicrob. Chemother. 1999, 43, 321-331.
4. Andriole, V.T. Current and future antifungal therapy: new targets for antifungal agents. J. Antimicrob. Chemother. 1999, 44, 151-162.
5. Kijjoa, A.; Sawangwong, P. Drugs and cosmetics from the Sea. Mar. Drugs 2004, 2, 73-82.
6. Proksch, P.; Ebel, R.E.; Ebel, R. Drugs from the sea-opportunities and obstacles. Mar. Drugs 2003, 1, 5-17.
7. Fontana, A.; Albarella, L.; Scognamiglio, G.; Uriz, M.; Cimino, G. Structural and stereochemical studies of C-21 terpenoids from Mediterranean Spongiidae sponges. J. Nat. Prod. 1996, 59, 869-872.
8. Rochfort, S. J.; Atkin, D.; Hobbs, L.; Capon, R.J. Hippospongins A-C: new furanoterpenes from Australian marine sponge Hippospongia sp. J. Nat. Prod. 1996, 59, 1024-1028.
9. Capon, R. J.; Jekins, A.; Rooney, F.; Ghisalberti, E. L. Structure revision and assignment of absolute stereochemistry of a marine C21 bisfuranoterpene. J. Nat. Prod. 2001, 64, 638-639.
10. Ryder, N.S.; Wagner, S.; Leitner, I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and others pathogenic yeasts. Antimicrob. Agents Chemother 1998, 42, 1057-1061.
11. Pfaller, M.A.; Messer, S.A.; Boyken, L.; Huynh, H.; Hollis, R.J.; Diekema, D.J. In vitro activities of 5-fluorocytosine against 8803 clinical isolates of Candida spp.: global assessment of primary resistance using national committee for clinical laboratory standards susceptibility testing methods. Antimicrob. Agents Chemother 2002, 46, 3518-3521.
12. Umeyama, A.; Shoji, N.; Arihara, S.; Ohizumi, Y.; Kobayashi, J. Untenospongin A and B, Novel furanoterpenes with coronary vasodilating activity from the Okinawan marine sponge Hippospongia sp. Aust. J. Chem. 1989, 42, 459-462.
13. Lemriss, S.; Marquet, B.; Ginestet, H.; Lefeuvre, L.; Fassouane, A.; Boiron, P. Screening of new antifungal compounds in a collection of chemical products. J. Mycol. Med. 2003, 13, 189-192.